Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
15
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | MSD | Economic Development and Industry | Government policy event relating to Ireland's life sciences sector (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2026 | MSD | Economic Development and Industry | National Life Sciences Strategy and competitiveness of Ireland's life sciences sector (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | EU Affairs | Ireland’s EU Council Presidency (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Life Science Strategy Public Consultation (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Engagement on Life Sciences and Innovation Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Energy and Natural Resources | Private Wires Legislation (Legislation) | 4 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Health and Innovation Policy (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Ireland’s Cervical Cancer Elimination Plan (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Healthcare Innovation (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines Funding in Budget 2024 (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Reimbursement of innovative medicines and vaccines (Matters involving public funds) | 2 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 11 | 73.3% | |
| Economic Development and Industry | 2 | 13.3% | |
| EU Affairs | 1 | 6.7% | |
| Energy and Natural Resources | 1 | 6.7% |